The Benefits and Risks of Smokeless Tobacco Products

Sep.06.2022
The Benefits and Risks of Smokeless Tobacco Products
Phillip Morris promotes non-combustible products as a safer alternative to smoking, backed by scientific evidence.

Smokers understand that smoking is harmful. However, data shows that most people are unaware that the primary issue with smoking is the smoke itself. When a cigarette is lit, it reaches high temperatures and the smoke produced from burning tobacco contains approximately 6,000 chemical compounds.


Approximately 100 substances have been identified by recognized public health authorities as harmful or potentially harmful. The high levels of these chemicals in cigarette smoke are the primary cause of smoking-related illnesses.


Innovation choice.


Innovative alternatives that eliminate combustion can release nicotine without producing smoke or ashes. While these products are still easily addictive and not without risks, they have the potential to significantly reduce the average levels of harmful chemicals compared to traditional cigarettes.


An independent study conducted by PMI has shown that 43% of respondents are confused by smoke-free products they have seen, read about or heard about. However, 76% of smokers would consider switching to less harmful alternatives if more information was available.


A woman snapped a cigarette in half. Source: PIXABAY new regulations.


In recent years, the market has seen an influx of new types of tobacco and nicotine products. Advances in technology and science have made it possible to develop smoke-free options, which while not without risk, may be a safer alternative for adult smokers who would otherwise continue to smoke traditional cigarettes.


More and more countries have implemented regulations on the use and distribution of alternative tobacco products that differ from traditional cigarettes. This allows adult smokers to transition to these product categories instead of continuing to smoke. Examples of such countries include the United States, Sweden, Japan, and the United Kingdom, which have also established very strict regulations on the use of traditional cigarettes.


Heating, non-burning products and non-flammable products do not produce smoke, which actually carries harmful substances that can cause tobacco-related diseases.


These products heat tobacco without burning it, significantly reducing the production of harmful chemicals. This innovative technology is backed by scientific evidence and marketing that differentiates and regulates such products can help adult smokers who would otherwise continue to smoke traditional cigarettes to switch to these alternatives and reduce their exposure to harmful chemicals.


The Power of Nicotine


Nicotine naturally occurs in tobacco leaves. This is one of the reasons why people smoke, besides factors such as taste and ritual. However, nicotine is not without risks, and can be addictive. Nevertheless, the primary cause of smoking-related diseases is the smoke, not the nicotine itself.


There are nine million smokers in Spain.


How do we address the over 1.3 billion smokers worldwide, with almost 9 million in Spain? Adult smokers who will continue to smoke should be treated in such a way that they are provided with accurate information based on scientific evidence, allowing them to make informed decisions.


Tar


One of the most harmful elements in cigarette smoke is known as "tar," which is not the same as the substance used for paving roads as some people mistakenly believe. Tar is a term used to refer to the thousands of chemicals released in cigarette smoke.


Two options


The best choice for adult smokers is to completely quit the use of tobacco and/or nicotine products.


However, as mentioned above, many of them will continue to smoke, which is the most harmful form of tobacco use.


In this situation, an increasing number of health authorities are recommending smoke-free products as a better choice for these consumers.


There are essentially two categories of products:


Electronic cigarettes use the energy from batteries to heat liquid containing nicotine and produce vapor, hence the term "vape". Additionally, they contain other substances such as propylene glycol, glycerin, flavorings, and other additives.


Heating tobacco products, used in conjunction with electronic devices, heats the tobacco without burning it, creating an aerosol instead of smoke.


Fake news.


According to the Unsmoke 2020 study conducted in collaboration with independent advisors Bovado and Phillip Morris, the smoking population in Spain is a victim of certain misconceptions about these products, and is unaware that non-combustible alternatives can help reduce smoking.


Half of the survey respondents indicated that the information they receive about e-cigarettes or heated tobacco products is contradictory or unclear. Meanwhile, 72% of those surveyed believe that authorities should allocate resources towards achieving the goal of providing scientifically verified new alternatives to help people quit smoking.


If they had more information about the differences between these alternative products and traditional cigarettes, even eight out of ten people would consider switching to them.


Philip Morris' bet


In summary, studies have confirmed that harmful substances generated from the burning of tobacco and cigarette smoke are the main causes of tobacco-related illnesses. For this reason, Philip Morris is committed to gradually replacing cigarettes with innovative smoke-free products.


Philip Morris is leading the paradigm shift in the industry, having spent over a decade researching and developing verified alternatives to traditional cigarettes. Since then, the company has been dedicated to developing and studying innovative non-combustible products that may be less harmful than traditional cigarettes.


Statement:


This article is compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the content. The compilation of this article is intended for industry exchange and research purposes.


Due to limitations in translation ability, the translated article may not fully express the original text. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macao, Taiwan, and foreign-related statements and positions.


The copyrights of the compiled information belong to the original media and authors. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Special Report|Japan Tobacco Buys CLEW: Can Its 160,000-Store Cigarette Network Help It Vie for U.S. Nicotine Pouch Share Against PMI and BAT?
Special Report|Japan Tobacco Buys CLEW: Can Its 160,000-Store Cigarette Network Help It Vie for U.S. Nicotine Pouch Share Against PMI and BAT?
Japan Tobacco Inc. (JT) announced on November 12, 2026, that it had acquired the U.S. assets of nicotine pouch brand CLEW from Nevcore Innovations Inc., including trademarks, intellectual property, product formulations and a Premarket Tobacco Product Application (PMTA). CLEW, currently distributed through selected outlets in 13 U.S. states, will immediately join the JTI LIGGETT portfolio. The transaction follows JT's approximately $2.4 billion acquisition of U.S. cigarette maker Vector Group in 2024. JTI LIGGETT says its existing cigarette brands reach more than 160,000 U.S. retail stores. During the 2026 NACS Show in October, JTI LIGGETT booth staff told 2Firsts that the company had not yet launched nicotine pouches in the United States. Although Nevcore previously announced FDA acceptance of CLEW's PMTA, the brand is absent from the agency's current list of authorized nicotine pouch products. JT has not disclosed a retail expansion plan for CLEW.
Business
Nov.12
Product | DOJO Launches 0+6ml BLAST7K Fresh in UK in September, Retaining 2+8ml Pod Compatibility Ahead of October Per-Milliliter Vaping Duty
Product | DOJO Launches 0+6ml BLAST7K Fresh in UK in September, Retaining 2+8ml Pod Compatibility Ahead of October Per-Milliliter Vaping Duty
DOJO officially launched the BLAST7K Fresh on September 17, 2026, introducing a UK-market prefilled pod product with 6ml of e-liquid and a manufacturer-rated capacity of up to 7,000 puffs. The device features a 1000mAh rechargeable battery, the INSTA-JUICED structure and COREX BLAST dual-mesh technology, while retaining compatibility with existing BLAST pods. The launch comes less than two weeks before the UK's Vaping Products Duty takes effect on October 1. At the new duty rate, 6ml of vaping liquid would correspond to £1.32 in VPD. DOJO has not stated that the product's 6ml format was designed in response to the new duty.
Sep.20
German Tobacco Tax Revenue Falls 10.8% Through August as Tax-Paid Cigarette Volume Drops 12.6%
German Tobacco Tax Revenue Falls 10.8% Through August as Tax-Paid Cigarette Volume Drops 12.6%
Germany collected €9.789 billion in total tobacco tax revenue from January through August 2026, down 10.8% from a year earlier, according to the Federal Ministry of Finance. Germany's tobacco tax base covers not only cigarettes and fine-cut tobacco but also heated tobacco and vaping liquids taxed as tobacco substitutes. The German Association of the Tobacco Industry and Novel Products, or BVTE, citing federal statistical data, said tax-paid cigarette volume fell 12.6% to 40.6 billion sticks. BVTE is using the latest figures to argue against further tax increases planned from 2027 through 2030, while Germany's parliament is scheduled to hold a first reading of the bill on September 24.
Sep.23
White House Pulls Heidi Overton's FDA Nomination as Vaccine, Abortion Pill and Vaping Disputes Fuel Senate Opposition
White House Pulls Heidi Overton's FDA Nomination as Vaccine, Abortion Pill and Vaping Disputes Fuel Senate Opposition
The White House withdrew Heidi Overton's nomination to lead the U.S. Food and Drug Administration (FDA) on November 17, 2026, a day before a scheduled Senate committee vote. Overton faced questions from Republican and Democratic senators over vaccines, abortion medication and flavored nicotine products. In May, the FDA granted its first marketing authorizations for non-tobacco, non-menthol e-cigarette flavors, including mango and blueberry pods from Glas. Republican Senator Susan Collins challenged recent authorizations for flavored vaping and nicotine pouch products during Overton's September confirmation hearing. The FDA remains under Acting Commissioner Kyle Diamantas.
FDA
Nov.18
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
Former BAT global content lead Andy Parton has left the company and launched Destreza, a London-based AI-native marketing consultancy. Parton previously worked across BAT's New Category brands Vuse, Velo and glo and had also served as Global Brand Lead for Vuse Go. Destreza says it will advise consumer businesses on AI in brand strategy, operating models, capability and agency configuration, using specialist AI agents to support research, strategy and creative development. BAT reported £3.621 billion in New Category revenue in 2025.
Sep.22
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives